Your browser doesn't support javascript.
loading
Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA.
Tian, Zelin; He, Weixiang; Tang, Jianing; Liao, Xing; Yang, Qian; Wu, Yumin; Wu, Gaosong.
Afiliación
  • Tian Z; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • He W; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Tang J; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Liao X; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Yang Q; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Wu Y; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
  • Wu G; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Onco Targets Ther ; 13: 6805-6817, 2020.
Article en En | MEDLINE | ID: mdl-32764968
INTRODUCTION: Breast cancer (BRCA) has the highest incidence among female malignancies, and the prognosis for these patients remains poor. MATERIALS AND METHODS: In this study, core modules and central genes related to BRCA were identified through a weighted gene co-expression network analysis (WGCNA). Gene expression profiles and clinical data of GSE25066 were obtained from the Gene Expression Omnibus (GEO) database. The result was validated with RNA-seq data from The Cancer Genome Atlas (TCGA) and Oncomine database. The top 30 key module genes with the highest intramodule connectivity were selected as the core genes (R2 = 0.40). RESULTS: According to TCGA and Oncomine datasets, seven genes were selected as candidate hub genes. Following further experimental verification, four hub genes (FAM171A1, NDFIP1, SKP1, and REEP5) were retained. CONCLUSION: We identified four hub genes as candidate biomarkers for BRCA. These hub genes may provide a theoretical basis for targeted therapy against BRCA.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Onco Targets Ther Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Onco Targets Ther Año: 2020 Tipo del documento: Article